4.7 Article

Protective effect of intestinal Blautia against neutropenic fever in allogeneic transplant recipients

Journal

CLINICAL INFECTIOUS DISEASES
Volume 75, Issue 11, Pages 1912-1920

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac299

Keywords

Blautia; hematopoietic cell transplantation; metabolomics; microbiota; neutropenic fever

Funding

  1. National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [KL2TR002492, UL1TR002494]
  2. NHLBI, NIH [K08HL143189]
  3. National Cancer Institute, NIH [NCI P30 CA008748]
  4. Parker Institute for Cancer Immunotherapy at MSKCC

Ask authors/readers for more resources

This study found that the gut microbiota Blautia can prevent neutropenic fever by improving intestinal health. Restoring Blautia may help reduce the incidence of neutropenic fever and related complications.
Background Neutropenic fever (NF) occurs in >70% of hematopoietic cell transplant (HCT) recipients, without a documented cause in most cases. Antibiotics used to prevent and treat NF disrupt the gut microbiota; these disruptions predict a higher posttransplantation mortality rate. We hypothesized that specific features in the gut microbial community may mediate the risk of NF. Methods We searched a large gut microbiota database in allogeneic HCT recipients (12 546 stool samples; 1278 patients) to find pairs with NF (cases) versus without NF (controls) on the same day relative to transplantation and with a stool sample on the previous day. A total of 179 such pairs were matched as to the underlying disease and graft source. Several other important clinical variables were similar between the groups. Results The gut microbiota of cases on the day before NF occurrence had a lower abundance of Blautia than their matched controls on the same day after transplantation, suggesting a protective role for Blautia. Microbiota network analysis did not find any differences in community structure between the groups, suggesting a single-taxon effect. To identify putative mechanisms, we searched a gut microbiome and serum metabolome database of patients with acute leukemia receiving chemotherapy and identified 139 serum samples collected within 24 hours after a stool sample from the same patient. Greater Blautia abundances predicted higher levels of next-day citrulline, a biomarker of total enterocyte mass. Conclusions These findings support a model in which Blautia protects against NF by improving intestinal health. Therapeutic restoration of Blautia may help prevent NF, thus reducing antibiotic exposures and transplantation-related deaths. In this multicenter multiomics study, we found that intestinal Blautia may protect against neutropenic fever in allogeneic transplant recipients by augmenting the intestinal epithelium. Blautia restoration may reduce the incidence of neutropenic fever, subsequent antibiotic exposures, and dysbiosis-related complications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available